Shilpa Medicare Ltd
Mr. Vishnukant is an indefatigable person and has vast business experience of APIs and Intermediates and presently leads the core business and functional teams of Shilpa which accelerate growth and performance by “Innovating for Affordable solutions”. He is the key strategy decision maker for successful API and Generics formulation. His determined efforts have led the company to a leading position in the Indian pharmaceutical domain and helped create a prominent presence for Oncology APIs globally. For his untiring efforts, Mr. Vishnukant was awarded “Best Entrepreneur Award” by Late Dr Shankar Dayal Sharma – the then President of India, in 1995. Other state honors conferred upon him were “Best Entrepreneur” from the Karnataka State Govt. in 1996; “Excellence in Exports” from Vishweshwarayya Industrial Trade Centre, Bangalore in 1996; and Export Excellence Award-2006” by FKCCI, Bangalore. Success seemed to be his second nature, for awards that kept following him like “First Runner Up” at the Emerging India Awards 2008 by CNBC TV18 at London and the “Best National Energy Conservation Award in Drugs & Pharmaceutical Sector for the year 2012” for energy sustainability in the Shilpa group by the then President of India, Dr. Pranab Mukherjee.
This person is not in any offices
Shilpa Medicare Ltd
Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug Delivery Systems, Peptides/Biotech products and Specialty Chemicals. The Company supplies oncology/non-oncology APIs and intermediates. Its oncology API products include Anastrozole, Axitinib, Azacitidine, Abiraterone Acetate, Bicalutamide, Bortezomib, Busulphan, Cabazitaxel Amorphous, Capecitabine, Carboplatin, Cladribine, Clofarabine, Zoledronic acid, Vismodegib, Pemetrexed DiPotassium Nonahydrate, Cyclophosphamide Monohydrate and Cytarabine. It also offers AntiRetroVirals. Its non-oncology API products include Acebrophylline, Echothiophate, Nifedipine, Perfenidone, PrucaloprideSuccinate, Sildenafil Citrate, Ursodeoxycholic acid and Dimethyl Fumarate.